3 ·Filed Jul 2, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Routine director onboarding — no immediate trading signal. Monitor for future Form 4 filings by Dr. Kreher to gauge insider sentiment. The appointment itself does not indicate a material change in company outlook.
Final — all horizons settled through T+60d ⚠ clustered
XERS ▲ +18.72% at T+60d
NEUTRAL call ✓ call won +18.72% · α vs SPY +15.15% · entry $8.28 → $9.83
T+1d
+1.09%
call +1.09% · α +0.21%
$8.37
settled 3mo ago
T+5d
+4.11%
call +4.11% · α +3.18%
$8.62
settled 3mo ago
T+20d
+1.69%
call +1.69% · α +2.11%
$8.42
settled 2mo ago
T+60d
+18.72%
call +18.72% · α +15.15%
$9.83
settled 4d ago
Price Chart
Loading chart...
Executive Summary
Dr. Nerissa Kreher has been appointed as a director of Xeris Biopharma Holdings, Inc., effective July 1, 2026, and filed a Form 3 initial statement of beneficial ownership. This is a routine administrative filing with no disclosure of actual holdings or material financial impact.
Key Facts
- Dr. Nerissa Kreher appointed as director, effective 2026-07-01
- Form 3 filed to report initial beneficial ownership (no ownership amounts disclosed)
- Power of Attorney granted to John Shannon, Beth Hecht, and Steve Pieper for Section 16 filings
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001867096-26-000051 |
| Document: 0001867096-26-000051-index-headers.html | 0001867096-26-000051 |
| Document: 0001867096-26-000051-index.html | 0001867096-26-000051 |
| Document: 0001867096-26-000051.txt | 0001867096-26-000051 |
14 reports for XERS
100% Hit rate best @ T+60▲ +24.89%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $7.71 $7.78 | ▲ +0.91% | ▲ +1.56% | $9.08 (+17.77%) |
Sep 1, 2026 4w ago | Insider Cluster | $8.58 $7.67 | ▼ −10.61% | ▼ −9.65% | $9.08 (+5.83%) |
Aug 6, 2026 8w ago | 8-K | $7.36 $8.33 | ▲ +13.18% | ▲ +11.97% | $9.08 (+23.37%) |
Aug 4, 2026 8w ago | Insider Cluster | $8.19 $8.39 | ▲ +2.44% | ▲ +2.54% | $9.08 (+10.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $8.94 $8.28 | ▲ +7.38% | ▲ +7.93% | $9.08 (−1.57%) |
Jul 2, 2026 13w ago | 3 | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jul 2, 2026 13w ago | Insider Cluster | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jun 30, 2026 13w ago | 8-K | $8.00 $8.94 | ▲ +11.75% | ▲ +11.49% | $9.08 (+13.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $6.79 $6.95 | ▲ +2.36% | ▲ +1.68% | $9.08 (+33.73%) |
Jun 5, 2026 16w ago | Insider Cluster | $6.24 $6.88 | ▲ +10.26% | ▲ +8.14% | $9.08 (+45.51%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Mon (64h 20m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access